OrthoPediatrics Corp. (KIDS) Financial Statements
OrthoPediatrics Corp. (KIDS) reported trailing twelve-month revenue of $252.7M (up 14.5% year on year) and net income of -$39.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$1.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
KIDSOrthoPediatrics Corp.Follow KIDS — free
—
Price chart with a free account
- Market cap
- 639.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.6 | 57.6 | 72.6 | 71.1 | 98.0 | 122.3 | 148.7 | 204.7 | 236.3 | 252.7 | |
| Gross profit | 34.5 | 42.7 | 54.6 | 55.0 | 73.4 | 90.7 | 111.3 | 148.6 | 172.7 | 186.1 | |
| Research & development | 3.4 | 4.7 | 5.7 | 5.3 | 5.5 | 8.5 | 10.9 | 11.0 | 9.1 | 9.1 | |
| Operating income | -6.5 | -9.6 | -9.1 | -26.8 | -18.0 | -25.4 | -26.8 | -35.0 | -39.2 | -30.0 | |
| Pre-tax income | -8.9 | -12.0 | -12.7 | -33.7 | -17.4 | -3.7 | -21.3 | -41.9 | -39.2 | -39.4 | |
| Income tax | 0.0 | 0.0 | 0.0 | -0.7 | -1.1 | -4.9 | -0.3 | -4.1 | 0.5 | 0.3 | |
| Net income | -8.9 | -12.0 | -13.7 | -32.9 | -16.3 | 1.3 | -21.0 | -37.8 | -39.6 | -39.7 | |
| Diluted EPS ($) | -5.86 | -0.96 | -0.94 | -1.82 | -0.84 | 0.06 | -0.92 | -1.64 | -1.69 | -1.68 | |
| Diluted shares (mn) | — | — | — | — | 19.3 | 20.9 | 22.7 | 23.1 | 23.5 | — |
USD millions · SEC XBRL
OrthoPediatrics Corp. — questions
- What is OrthoPediatrics Corp.'s revenue?
- $252.7M over the twelve months to 2026-06-30, up 14.5% year on year, from its 10-Q and 10-K filings.
- What is OrthoPediatrics Corp.'s net income?
- -$39.7M over the twelve months to 2026-06-30.
- What is OrthoPediatrics Corp.'s free cash flow?
- -$1.8M over the twelve months to 2026-06-30.
- What are OrthoPediatrics Corp.'s diluted earnings per share?
- $-1.68 over the twelve months to 2026-06-30.
Every figure on this page comes from OrthoPediatrics Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.